ADMA Biologics Inc (ADMA): Price and Financial Metrics
ADMA Price/Volume Stats
Current price | $6.27 | 52-week high | $6.76 |
Prev. close | $6.20 | 52-week low | $3.06 |
Day low | $6.10 | Volume | 3,411,865 |
Day high | $6.29 | Avg. volume | 2,659,693 |
50-day MA | $5.93 | Dividend yield | N/A |
200-day MA | $4.47 | Market Cap | 1.43B |
ADMA Stock Price Chart Interactive Chart >
ADMA Biologics Inc (ADMA) Company Bio
ADMA Biologics, Inc. develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The company was founded in 2004 and is based in Ramsey, New Jersey.
Latest ADMA News From Around the Web
Below are the latest news stories about ADMA BIOLOGICS INC that investors may wish to consider to help them evaluate ADMA as an investment opportunity.
Cytokinetics (CYTK) Up 83% as Cardiomyopathy Drug Meets GoalsCytokinetics (CYTK) reports positive results from its pivotal late-stage study of aficamten in symptomatic obstructive hypertrophic cardiomyopathy patients. The stock rallies 83% in response. |
Milestone Pharma (MIST) Down on Regulatory Update for EtripamilMilestone Pharma (MIST) plunges 31% following an RTF letter from the FDA due to insufficient data to begin a substantive review of the regulatory filing for etripamil nasal spray to treat PSVT. |
Merck (MRK) & Daiichi Sankyo's Lung Cancer ADC Gets Priority TagMerck (MRK) and Daiichi Sankyo's regulatory filing for HER3-DXd gets the FDA's priority review grant for the treatment of adult patients with lung cancer. A final decision is expected on Jun 26, 2024. |
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?According to the average brokerage recommendation (ABR), one should invest in Adma Biologics (ADMA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock? |
Should You Buy Adma Biologics (ADMA) After Golden Cross?Is it a good or bad thing when a stock experiences a golden cross technical event? |
ADMA Price Returns
1-mo | -0.79% |
3-mo | 25.15% |
6-mo | 98.42% |
1-year | 82.27% |
3-year | 315.23% |
5-year | 35.71% |
YTD | 38.72% |
2023 | 16.49% |
2022 | 175.18% |
2021 | -27.69% |
2020 | -51.25% |
2019 | 67.36% |
Continue Researching ADMA
Want to do more research on Adma Biologics Inc's stock and its price? Try the links below:Adma Biologics Inc (ADMA) Stock Price | Nasdaq
Adma Biologics Inc (ADMA) Stock Quote, History and News - Yahoo Finance
Adma Biologics Inc (ADMA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...